Abstract
Nuclear medicine has an important role in the management of benign and malignant bone diseases. This role has been expanding significantly particularly in the diagnosis of many benign diseases which may not be detected by morphologic modalities. Table 7.1 summarizes the modalities used in the diagnosis of bone diseases and their main advantages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Coleman RE (1997) Skeletal complications of malignancy. Cancer 80(Suppl):1588–1594
Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165–176
Elgazzar A (2015) Orthopedic nuclear medicine. Springer, Berlin
Elgazzar AH, Sarikaya I (2018) Nuclear medicine companion; A case-based practical reference for daily use. Springer, Berlin
Evan-Sapir E (2005) Imaging of malignant bone involvement by morphologic, scintigraphic and hybrid modalities. J Nucl Med 46:1356–1367
Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Cancer Base No. 5. IARC Press, Lyon Available at: http://www-dep.iarc.fr/globocan/cdrom.htm
Palestro C (2015) Radionuclide imaging of osteomyelitis. Semin Nucl Med 45:32–46
Raghavan M, Lazzeri E, Palestro CJ (2018) Imaging of spondylodiscitis. Semin Nucl Med 4:131–147
Schauwecker DS (1992) The scintigraphic diagnosis of osteomyelitis. Am J Roentgenol 158:9–18
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Elgazzar, A.H., Alenezi, S. (2020). Nuclear Medicine in the Musculoskeletal System. In: A Concise Guide to Nuclear Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-26064-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-26064-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26063-7
Online ISBN: 978-3-030-26064-4
eBook Packages: MedicineMedicine (R0)